GALANTAMIN-MINITABLETTEN

European patent · EP4615421 · In force

Register entry

Publication number
EP4615421
Application number
EP23800861
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 6, 2023
Published
Sep 17, 2025
Granted
Sep 2, 2026
Protection ends at the latest
Nov 5, 2043
Next annual fee due
Nov 30, 2026
IPC classes
A61K 9/16 (2006.01)
A61K 9/20 (2006.01)
A61K 31/55 (2006.01)
Priority
EP 22205887 07.11.2022
PCT application
PCT/EP2023/080852 06.11.2023
PCT publication
WO2024/099974 16.05.2024
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 10, 2026

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 10.09.2026

  2. Sep 2, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 02.09.2026

Parties

Holder

Rejuvenate Biomed NV

Bioville Agoralaan A-bis, 3590 Diepenbeek, BE

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

BELIËN, Ann

3590 Diepenbeek, BE

CORVELEYN, Sam

3590 Diepenbeek, BE

VERHOEVEN, Ellen

9052 Gent, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.